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Soon after the novel coronavirus, SARS-CoV-2 (2019-nCoV), was first identified in a cluster of 
patients with pneumonia (Li Q et al, 2020), in the Chinese city of Wuhan on 31 December 
2019, rapid human to human transmission was anticipated (Hui D et al, 2020). The fast pace 
of transmission is wreaking havoc and stirring media hype and public health concern (Ippolito 
G et al, 2020) globally.  When the World Health Organization (WHO) declared the disease, 
(now officially named COVID-19) a Public Health Emergency of International Concern (PHEIC) 
on 31st January 2020 (WHO, 2020a), the Director General Dr Tedros Ghebreyesus justified the 
decision by stating that WHOs greatest concern was the potential for the virus to spread to 
countries with weaker health systems. Repeated outbreaks of other preventable emerging and 
re-emerging infectious diseases with epidemic potential have taken their toll on the health 
systems of many African countries. The devastating 2014–2016 Ebola Virus Epidemic (WHO 
2020b) in West Africa, demonstrated how ill-prepared the affected countries were to rapidly 
identify the infection and halt transmission (WHO 2020d; Largent EA et al, 2016; Hoffman SJ 
et al, 2018; Omoleke SA et al, 2016). Similarly, the smoldering remnants of the 2018-19 Ebola 
Virus outbreak in the Democratic Republic of Congo, have demonstrated even for health 
services with considerable experience of dealing with a certain emerging pathogen, 
geography and sociopolitical instability, can hamper the response (Aruna et al 2019).  
A recent analysis of the spatial and temporal distribution of infectious disease epidemics, 
disasters and other potential public health emergencies in the WHO Africa Region highlighted 
that 41 African countries (87% of the continent) had at least one epidemic, and 21 countries 
(45%) had at least one epidemic annually (Talisuna A et al, 2020). The top five causes of 
epidemics were Cholera, Measles, Viral haemorrhagic diseases, malaria and meningitis. Seven 
countries which experienced over 10 events, all had limited International Health Regulations 
(IHR) capacities which are now being developed. Most sub-Saharan African countries are 
operating at maximum capacity with the huge existing workload in hospitals and clinics. The 
WHO’s Joint External Evaluation reports, conducted since 2016, suggest that the ability to 
respond to an International Health Regulation hazard, such as the importation of an infectious 
Jo
urn
al 
Pre
-pr
oo
f
4 
 
disease like COVID-19, requires almost universal improvement across sub-Saharan Africa 
(WHO, 2020c).Thus, it is essential for African countries to take the lead, become proactive 
and prepare surveillance systems for the rapid detection of any imported cases of COVID-19, 
to prevent rapid spread as seen in China. The question arises, ‘Is Africa prepared and 
equipped to deal with yet another outbreak of a highly infectious disease – COVID-19?  
The answer to the question is, is better prepared than ever before. Substantial progress has 
been made since the 2014-16 Ebola outbreak (WHO 2020d), with lessons learned from 
previous and ongoing outbreaks, followed by significant investments into surveillance and 
preparedness (WHO 2020d; Largent EA et al, 2016; Hoffman SJ et al, 2018; Omoleke SA et al, 
2016). Africa is now better prepared than ever before. Thus, African countries have been on 
heightened alert to detect and isolated any imported cases of COVID-19. There has been rapid 
response to the COVID-19 epidemic from Africa’s public health systems, well before any cases 
of COVID-10 had been reported form Africa. This response has been made possible with the 
re-organization of the WHO including the creation of the World Health Emergencies 
Programme; the establishment of the Africa Centers for Disease Control and Prevention 
(Africa CDC, 2020) and creation and funding of consortia such as the ONE-HUMAN-ANIMAL-
HEALTH Africa-Europe research, training and capacity development network (PANDORA-ID-
NET)(Pandora-ID-NET 2020) for tackling emerging and re-emerging infections with epidemic 
potential.  This ONE-HEALTH network works effectively and equitably together across all 
Africa regions, fully engaging with national disease control authorities and public health 
institutes, in close liaison with the Nigeria CDC, Africa CDC and other African and global 
public health agencies. Importantly, this consortium has allowed strengthening of 
communication and establishment of trust and ‘unity of purpose’ between African 
governments, Africa CDC, Nigeria CDC (Nigeria CDC, 2020), local communities and the 
PANDORA-ID-NET consortium local African and European public health workers and scientists.   
An estimated 2 million Chinese nationals live and work in Africa, and there is increasing travel 
in the opposite direction, with people going to China for education, business and leisure.  
Prior to the travel restrictions imposed after the COVID-19 outbreak, there were an average 
of eight flights a day operated between China and African cities (Haider et al, 2020).  There 
are ongoing efforts in Africa to prepare to deal with imported cases or subsequent local 
outbreaks of COVID-19, led by the Africa CDC, Nigeria CDC, African Union, PANDORA-ID-NET 
and other research and capacity development and training consortia. Many African countries 
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have already introduced screening of arrivals for COVID-19 at airports, and at some seaports. 
‘First public health emergency responders’ from African countries met in Senegal in early 
February 2020 to equip themselves with the latest advances on COVID-19 diagnostics, 
prevention and healthcare knowledge. Over 20 African nations are now able to test for COVID-
19. Several African countries have identified isolation and quarantine centers and Nigeria, 
Kenya, Ethiopia, Ivory Coast, Ghana, Uganda and Botswana have rapidly dealt with suspected 
cases carrying out laboratory tests, and in some cases, placing them in quarantine while 
laboratory tests were performed.  
Nigeria was one of the first countries to recognize the risk and start planning the response for 
COVID-19.  In a massive effort of national coordination, a multi-sectoral National Coronavirus 
Preparedness Group was established by Nigeria CDC on January 7 2020, one week after China 
first reported the cases and three weeks before WHO declared the disease to be of 
international concern. The country has also established diagnostic capacity for COVID-19 in 
three laboratories within the country in one month. Nigeria CDC has established a national 
team that meets daily to assess the risk coronavirus poses to the nation and review its 
response to it. Uganda quarantined more than 100 people who arrived at Entebbe 
International Airport, some at hospitals in Entebbe and Kampala, and others were confined in 
their homes. Zambia has dedicated two medical facilities in the capital, Lusaka, to 
quarantine people suspected of having the disease. They include designating a new 800-bed 
hospital in Lusaka, funded and built by China development aid to Zambia. Thermal body 
scanners have also been set up at all ports of entry to detect travelers showing symptoms of 
the virus. Kenya has introduced mandatory screening at all ports of entry, and established 
isolation facilities and a rapid response team to handle suspected cases. South Africa has set 
up national and provincial response teams, designated 300 health officials to ports of entry 
and begun screening all travelers from China. The Africa CDC has trained numerous 
participants from across Africa, including Egypt, on enhancing detection of COVID-19 at 
points-of-entry in collaboration with US-CDC, WHO, and the International Civil Aviation 
Authority (WHO 2020e). Two airlines, Kenya Airways and South African Airlines, were also 
represented in the training. In the next two weeks, further training and resources will be 
provided to Egypt and other at-risk countries for infection prevention and control in 
healthcare facilities, medical management of COVID-19, and risk communication and 
community engagement. The Africa Union, West African Health Organization (WAHO) and 
external donors have been quick to provide support to the Africa CDC. In response to 
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emergency grant calls for COVID-19, there have been several consortia fielding grant 
applications for research and capacity development. 
The long anticipated and inevitable and detection of the introduction of SARS-CoV-2 into 
Africa was announced on 14 February 2020, by the Minister of Health and Population of Egypt, 
Dr Hala Zayed, who confirmed the first case of the novel coronavirus disease COVID-19 in 
Egypt. The patient was a 33 yearold male of foreign origin whose 17 contacts tested negative 
but are under home quarantine for 14 days. This has ignited a reflection on the readiness of 
the continent to take on the challenge and showcase its new potential. Following detection of 
this first case in Africa, the Africa CDC, Nigeria CDC and other national public health 
institutes in liaison with the WHO are scaling up preparedness efforts in the African region, 
supporting countries to implement recommendations outlined by the WHO International 
Health Regulations Emergency Committee. The Emergency Committee recommended that all 
countries should be prepared for containment, including active surveillance, early detection, 
isolation and case management, contact tracing and prevention of onward spread of SARS-
CoV-2. Thirteen nations with close links with China, including Nigeria, South Africa, Kenya and 
the Democratic Republic of the Congo, have been identified as especially high-risk priority 
zones for proactive surveillance, detection and containing the spread of COVID-19.  The WHO 
has sent diagnostic kits to 29 laboratories in Africa, and reagents and positive controls are 
being shipped worldwide by PANDORA-ID-NET partner in Germany, Charité-
Universitätsmedizin Berlin Institute of Virology, to ensure the capacity to screen and test. 
Some countries in Africa, including DRC, are also leveraging the capacity they have built up to 
test for Ebola, to test for COVID-19.   Thus, early detection of cases with implementation of 
infection control procedures will remain a priority to control the spread of COVID-19 in Africa. 
On 22nd February an Emergency Ministerial meeting on COVID-19 was organized by the African 
Union and the Africa Centres for Disease Control and Prevention following which the WHO DG 
announced several additional measures and plans for supporting the Africa response to COVID-
19 (WHO 2020h). He appointed Dr John Nkengasong, Director of the Africa CDC, and Professor 
Samba Sow, Director-General of the Center for Vaccine Development in Mali, as special 
envoys on COVID-19, to provide strategic advice and high-level political advocacy and 
engagement in Africa. A WHO Strategic Preparedness and Response Plan has been developed, 
with a call for US$675 million to support support those African countries which are most 
vulnerable. WHO have also shipped over 30,000 sets of personal protective equipment to 
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several countries in Africa, and 60,000 more sets are to be shipped to the 19 vulnerable 
countries in the coming weeks. During the past month about 11,000 African health workers 
have been trained using WHO’s online courses on COVID-19, which are available free of 
charge in English, French and other languages at OpenWHO.org. 
As of 22nd February 2020, there were 77,794 confirmed cases of COVID-19 reported to the 
WHO (WHO, 2020f; China CDC, 2020). Of these 702,528 were from China with 2,348 deaths, 
and 1402 from 28 countries outside China with 11 deaths. Given the extent of the outbreak in 
China, and with a high degree of awareness of COVID-19 in Africa, and proactive screening on 
the rise, more COVID-19 cases are anticipated in Africa.  Several lessons have been learnt 
from the SARS-CoV-2 epidemic, which is the third lethal human zoonotic coronavirus with 
epidemic potential to emerge past 2 decades, the first being SARS-CoV identified in 2002 and 
second MERS-CoV in 2012 (Hui DS et al, 2014; McCloskey B et al, 2014). Whilst the news and 
social media hype has evoked public and political anxieties, it is important to note that 
COVID-19 appears to have less than 3% mortality rates and is not more serious than outbreaks 
of viral respiratory tract infections such as influenza (Ippolito G et al, 2020). It is crucial that 
other communicable diseases which impact a higher toll and burden on health services in 
Africa are not neglected or sidelined by the current hype and scaremongering of the COVID-19 
epidemic. 
An important need remains for ensuring long-term sustainability of what is being built. Africa 
needs to continue its upward trajectory of activities so as to align public health resources, 
scientific expertise and experience, and political commitment so that any future infectious 
disease outbreaks can be stopped before they become an epidemic in Africa. Africa needs 
more investments into ONE-HEALTH collaborative activities across the continent in order to 
meet the challenges of current and future public health threats (Kock R,et al  2019; Petersen 
E et al, 2019; Talisuna AO et al, 2020; Hui DS et al, 2020; Zumla A et al, 2016). A whole new 
young generation of enthusiastic, committed and dedicated African public health workers, 
epidemiologists, researchers, healthcare workers and laboratory personnel have emerged over 
the past 5 years, and they need to be supported by security of funding to build their careers 
and sustain their take forward their research and training portfolios. The future of Africa’s 
public health security relies on them. Increased governmental and donor investments are 
required to advance locally led, world-class public health work with surveillance, data and 
analytics capabilities and further expanding state-of-the-art laboratory capacities with more 
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trained personnel to sustain capacity to rapidly respond to outbreaks at their source. A well-
planned long-term strategy from the Africa Union will add major value for consolidating 
African leadership of public health capacity building, training and research.  
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